Rimonabant acom - Study guides, Class notes & Summaries
Looking for the best study guides, study notes and summaries about Rimonabant acom? On this page you'll find 1 study documents about Rimonabant acom.
All 1 results
Sort by
-
RNSG MISC: PU48 EXAMS 2024 LATEST UPDATED QUESTIONS WITH EXPLAINED CORRECT ANSWERS
- Exam (elaborations) • 105 pages • 2024
- $14.49
- + learn more
Which of the following medications used for obesity improves cardiovascular disease risk factors in obese patients with metabolic syndrome? You Selected: • Rimonabant (Acomplia) Correct response: • Rimonabant (Acomplia) Explanation: Acomplia is the newest medication used to treat obesity. It stimulates weight reduction and improves cardiovascular disease risk factors in obese patients with metabolic syndrome. Meridia was recently pulled from the market because of the increased ...
As you read this, a fellow student has made another $4.70
